Gilmore O’Neill
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Gilmore O’Neill
Gilmore O’Neill is recorded as CEO at Editas Medicine, Inc. (EDIT). The proxy statement of Editas Medicine, Inc. reports total compensation of $2,353,655 for Gilmore O’Neill in fiscal 2025, including a base salary of $686,574. Disclosed compensation is on record for 8 fiscal years. Gilmore O’Neill has spoken on 8 earnings calls and 2 other investor events across 1 company, most recently for Editas Medicine, Inc. on June 4, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Sarepta Therapeutics, Inc. (SRPT)
Proxy statement
Start not stated–2022-04-25
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Editas Medicine, Inc.
Other people whose current roles at this company are on record from its filings.
- Gilmore O'Neill, M.B., M.M.Sc. CEO, Board Member
- James C. Mullen CEO
- Katrine S. Bosley CEO
- Jessica Hopfield Chairman
- Amy Parison CFO
- Andrew A. F. Hack CFO
- Eric Ek CFO
- Erick J. Lucera CFO
- Vic Myer CTO
- Bernadette Connaughton Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Editas Medicine, Inc. (EDIT) | M.B., M.M.Sc. President and Chief Executive Officer | $686,574 | $2,353,655 |
| 2024 | Editas Medicine, Inc. (EDIT) | M.B., M.M.Sc. President and Chief Executive Officer | $667,100 | $5,126,868 |
| 2023 | Editas Medicine, Inc. (EDIT) | M.B., M.M.Sc. President and Chief Executive Officer | $641,092 | $2,392,309 |
| 2022 | Editas Medicine, Inc. (EDIT) | M.B., M.M.Sc. President and Chief Executive Officer | $355,769 | $9,058,900 |
| 2020 | Sarepta Therapeutics, Inc. (SRPT) | M.B., M.M.Sc. Executive Vice President, Chief Scientific Officer ^^ | $583,277 | $3,790,049 |
| 2019 | Sarepta Therapeutics, Inc. (SRPT) | M.B., M.M.Sc. Executive Vice President, Chief Scientific Officer ^^ | $563,962 | $5,168,110 |
| 2018 | Sarepta Therapeutics, Inc. (SRPT) | M.B., M.M.Sc. Executive Vice President, Chief Scientific Officer ^^ | $310,962 | $6,449,176 |
| 2017 | Sarepta Therapeutics, Inc. (SRPT) | M.B., M.M.Sc. Executive Vice President, Chief Scientific Officer ^^ | — | — |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.